Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Brief Summary:
This study will evaluate the intraocular pressure-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty in patients with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication.
Study Type: Interventional (Clinical Trial)
Estimated Enrollment: 215 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Actual Study Start Date: August 27, 2015
Estimated Primary Completion Date: May 30, 2023
Estimated Study Completion Date: May 30, 2023
Arm:
- Experimental: Bimatoprost Sustained-Release (SR)
- Active Comparator: Selective Laser Trabeculoplasty (SLT)
| Category | Value |
|---|---|
| Study type(s) | Interventional |
| Estimated enrolment | 215 |
| Actual Study start date | 27 August 2015 |
| Estimated Study Completion Date | 30 May 2023 |